1.      Timp JF, Braeken SK, Versteeg HH, Cannegieter SC.  Epidemiology of cancer-associated venous thrombosis. Blood 2013;122:1712-23.

2.     Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 2009;27:4839-47.

3.     Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: Burden, mechanisms, and management. Thromb Haemost 2017;117:219-30.

4.     Connolly GC and Francis CW. Cancer-associated thrombosis. Hematology Am Soc Hematol Educ Program. 2013;2013:684-91.

5.     Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis. PLoS Med 2012;9:e1001275.

6.     Posch F, Riedl J, Reitter EM, Kaider A, Zielinski C, Pabinger I, Ay C. Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A multi-state model. Thromb Haemost 2016;115:817-26.

7.     Khalil J, Bensaid B, Elkacemi H, Afif M, Bensaid Y, Kebdani T, Benjaafar N. Venous thromboembolism in cancer patients: An underestimated major health problem. World J Surg Oncol 2015;13:204.

8.     Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007;110:2339–46.